UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$361M |
| 2 |
Microsoft
MSFT
|
+$311M |
| 3 |
TAL Education Group
TAL
|
+$292M |
| 4 |
Salesforce
CRM
|
+$248M |
| 5 |
Apple
AAPL
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$530M |
| 2 |
Meta Platforms (Facebook)
META
|
+$215M |
| 3 |
Eli Lilly
LLY
|
+$150M |
| 4 |
AET
Aetna Inc
AET
|
+$110M |
| 5 |
LyondellBasell Industries
LYB
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.78% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 11.64% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Southside Bancshares
SBSI
$967M
| $619K | ﹤0.01% |
17,821
+7,214
| +68% | +$251K |
|
1902
TFS Financial
TFSL
$4.93B
| $618K | ﹤0.01% |
42,049
+6,900
| +20% | +$103K |
|
1903
Zillow
ZG
$7.63B
| $617K | ﹤0.01% |
11,423
| – | – |
|
1904
Iovance Biotherapeutics
IOVA
$2.87B
| $614K | ﹤0.01% |
36,308
+26,047
| +254% | +$394K |
|
|
SNBR
1905
DELISTED
Sleep Number
SNBR
| $607K | ﹤0.01% |
17,276
| – | – |
|
1906
Safety Insurance
SAFT
$1.52B
| $607K | ﹤0.01% |
7,896
| – | – |
|
|
ACOR
1907
DELISTED
Acorda Therapeutics
ACOR
| $607K | ﹤0.01% |
214
+21
| +11% | +$62.9K |
|
1908
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| $607K | ﹤0.01% |
9,866
+1,332
| +16% | +$83.2K |
|
1909
Huazhu Hotels Group
HTHT
$13B
| $606K | ﹤0.01% |
18,400
+10,800
| +142% | +$395K |
|
1910
Tennant Co
TNC
$1.26B
| $606K | ﹤0.01% |
8,948
+3,365
| +60% | +$229K |
|
1911
Antero Midstream
AM
$10.1B
| $606K | ﹤0.01% |
+37,884
| New | +$733K |
|
|
FMI
1912
DELISTED
Foundation Medicine, Inc.
FMI
| $606K | ﹤0.01% |
7,692
+4,157
| +118% | +$307K |
|
|
NTUS
1913
DELISTED
Natus Medical Inc
NTUS
| $604K | ﹤0.01% |
17,940
+1,813
| +11% | +$57.4K |
|
|
KNL
1914
DELISTED
Knoll, Inc.
KNL
| $601K | ﹤0.01% |
29,778
+3,105
| +12% | +$68.7K |
|
1915
Nice
NICE
$5.97B
| $601K | ﹤0.01% |
6,400
-76
| -1% | -$7.08K |
|
1916
Customers Bancorp
CUBI
$2.77B
| $601K | ﹤0.01% |
20,613
+10,213
| +98% | +$307K |
|
1917
PJT Partners
PJT
$4.38B
| $600K | ﹤0.01% |
11,986
+1,100
| +10% | +$53K |
|
|
MODV
1918
DELISTED
ModivCare
MODV
| $600K | ﹤0.01% |
8,675
+5,100
| +143% | +$333K |
|
1919
Enterprise Financial Services Corp
EFSC
$2.39B
| $599K | ﹤0.01% |
12,765
+1,297
| +11% | +$61.9K |
|
|
NRE
1920
DELISTED
NorthStar Realty Europe Corp.
NRE
| $597K | ﹤0.01% |
45,882
+13,900
| +43% | +$163K |
|
1921
Diodes
DIOD
$4.84B
| $597K | ﹤0.01% |
19,600
+2,319
| +13% | +$69.4K |
|
1922
Atara Biotherapeutics
ATRA
$76.1M
| $596K | ﹤0.01% |
+612
| New | +$558K |
|
|
ICPT
1923
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $596K | ﹤0.01% |
9,680
| – | – |
|
|
ATSG
1924
DELISTED
Air Transport Services Group
ATSG
| $595K | ﹤0.01% |
25,525
+11,925
| +88% | +$293K |
|
|
ARR
1925
Armour Residential REIT
ARR
$2.36B
| $591K | ﹤0.01% |
5,073
+2,257
| +80% | +$264K |
|
Similar funds
UBS AM's Q1 2018 Portfolio in Review
As of Q1 2018, UBS AM held 2,716 positions worth $127B, up 7.4% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS AM deployed $8.54B of net new capital in Q1 2018, opening 143 new positions and adding to 1,776 existing holdings. Its largest new stake was Nutrien: 1,905,754 shares worth $90M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Broadcom, an estimated $530M trimmed.
- UBS AM's largest Q1 2018 buy was Nutrien: 1,905,754 shares worth $90M.
- UBS AM added most to Alibaba in Q1 2018, an estimated $361M increase.
- UBS AM's biggest Q1 2018 reduction was Broadcom, cutting an estimated $530M.
- UBS AM fully exited Agrium in Q1 2018, selling an estimated $37.4M.
- UBS AM's ten largest holdings make up 17% of its $127B portfolio in Q1 2018.
- UBS AM opened 143 new positions and closed 63 in Q1 2018.
- UBS AM's portfolio value rose 7.4% quarter-over-quarter to $127B.
Based on UBS AM's 13F filing for Q1 2018, filed 14 May 2018.